Aldeyra Therapeutics (ALDX) Insider Trading & Ownership $5.34 +0.11 (+2.10%) (As of 10/4/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Aldeyra Therapeutics (NASDAQ:ALDX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage8.50%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$1.47 MNumber OfInsiders Selling(Last 12 Months)3Amount OfInsider Selling(Last 12 Months)$4.82 M Get ALDX Insider Trade Alerts Want to know when executives and insiders are buying or selling Aldeyra Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ALDX Insider Buying and Selling by Quarter Ad Insiders ExposedHas Trump Finally Gone Too Far?Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.Register For The Webinar To Discover Aldeyra Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails4/5/2024Perceptive Advisors LlcMajor ShareholderBuy37,712$4.74$178,754.88 4/3/2024Perceptive Advisors LlcMajor ShareholderBuy309,847$4.09$1,267,274.23 4/1/2024Perceptive Advisors LlcMajor ShareholderBuy8,374$3.25$27,215.50 3/11/2024Bruce GreenbergInsiderSell13,201$3.41$45,015.41 3/11/2024Todd C BradyCEOSell97,914$3.27$320,178.78 10/18/2023Perceptive Advisors LlcMajor ShareholderSell306,499$1.74$533,308.26 10/16/2023Perceptive Advisors LlcMajor ShareholderSell2,450,000$1.60$3,920,000.00 (Data available from 1/1/2013 forward) ALDX Insider Trading Activity - Frequently Asked Questions Who is on Aldeyra Therapeutics's Insider Roster? The list of insiders at Aldeyra Therapeutics includes Bruce Greenberg, Martin Joseph Joyce, Perceptive Advisors Llc, and Todd C Brady. Learn more on insiders at ALDX. What percentage of Aldeyra Therapeutics stock is owned by insiders? 8.50% of Aldeyra Therapeutics stock is owned by insiders. Learn more on ALDX's insider holdings. Which Aldeyra Therapeutics insiders have been buying company stock? The following insider purchased ALDX shares in the last 24 months: Perceptive Advisors Llc ($1,473,244.61). How much insider buying is happening at Aldeyra Therapeutics? Insiders have purchased a total of 355,933 ALDX shares in the last 24 months for a total of $1,473,244.61 bought. Which Aldeyra Therapeutics insiders have been selling company stock? The following insiders have sold ALDX shares in the last 24 months: Bruce Greenberg ($45,015.41), Perceptive Advisors Llc ($4,453,308.26), and Todd C Brady ($320,178.78). How much insider selling is happening at Aldeyra Therapeutics? Insiders have sold a total of 2,867,614 Aldeyra Therapeutics shares in the last 24 months for a total of $4,818,502.45 sold. Aldeyra Therapeutics Key ExecutivesTodd C. Brady (Age 48)M.D., Ph.D., Chief Executive Officer and Director Joshua Reed (Age 47)Chief Financial Officer David McMullin (Age 45)Chief Commercial Officer James A. Gow (Age 53)M.D., Senior Vice President of Clinical Development Stephen G. Machatha (Age 43)Ph.D., Senior Vice President, Technical Operation More Insider Trading Tools from MarketBeat Related Companies: NATR Insider Trading VSTM Insider Trading VRCA Insider Trading VYNE Insider Trading ANIP Insider Trading XNCR Insider Trading DAWN Insider Trading ELVN Insider Trading INVA Insider Trading TYRA Insider Trading Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: Insiders Are Betting Big on These 2 StocksThis Is the Top Large-Cap Stock Insiders Are BuyingMatador Resources Insiders Keep Buying Its Stock, Should You?Top 3 Small-Cap Stocks Insiders Are Buying Right Now3 Small Cap Stocks That Insiders Are Buying This page (NASDAQ:ALDX) was last updated on 10/6/2024 by MarketBeat.com Staff From Our PartnersThe panic button has already been pressedIf you missed it, my emergency election broadcast is now available on replay.Porter & Company | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredKamala’s Dirty Election Move… RevealedAccording to former advisor to the CIA, the Pentagon and the White House Jim Rickards… Kamala and her puppe...Paradigm Press | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | Sponsored320 hedge funds just sold this stock320 hedge funds just sold this stock A strange force has seized control of Wall Street. Hedge funds are alr...Chaikin Analytics | SponsoredAI Expert Reveals New PickEveryone’s talking about AI right now, but I’ve been talking about it for years. And now I’ve just released...Brownstone Research | SponsoredHow much money are you leaving on the table from the stocks you already own?Charles Payne here, and I want to let you in on a time-tested trading method that can be used to generate cash...Unstoppable Prosperity | SponsoredGolden Equation: Volatility = OpportunityWhen the market swings wildly, most investors panic… But it doesn't have to be this way. You see, when t...Prosper Trading Academy | Sponsored Adding Choose a watchlist: Watchlist My Default Watchlist Adding Aldeyra Therapeutics, Inc You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Share Aldeyra Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.